Comparison of two different drugs, hyperbaric Ropivacaine 0.75% and hyperbaric Levobupivacaine 0.5% in spinal anaesthesia for daycare infraumbilical surgeries.
Phase 1
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: 7- Osteopathic
- Registration Number
- CTRI/2023/11/059543
- Lead Sponsor
- DrKewal Krishan Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients scheduled for elective day care infraumbilical surgeries under spinal anaesthesia.
2.Patients aged between 18-70 years of either gender, giving valid informed and written consent.
3.Patients belonging to American Society of Anaesthesiology (ASA) grade I or II.
Exclusion Criteria
1.Patient with any contraindication to spinal anaesthesia.
2.History of anaphylaxis to local anaesthetics and allergy to study drugs.
3.Obese patients with BMI >30kg/m2.
4.Patients with cardiac history such as CAD, MI, CHF, dysrhythmias, valvular disease, uncontrolled hypertension, and DM.
5.Patient having any history of psychiatric illness, or substance abuse, or chronic alcoholic.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the regression of spinal anaesthesia effect with hyperbaric Ropivacaine 0.75% in day care infraumblical surgeries under spinal anaesthesia. <br/ ><br> <br/ ><br>2.To evaluate the regression of spinal anaesthesia effect with hyperbaric Levobupivacaine 0.5% in day care infraumblical surgeries under spinal anaesthesia. <br/ ><br> <br/ ><br>3.To compare the both. <br/ ><br>Timepoint: outcome will be assessed at the end of study.
- Secondary Outcome Measures
Name Time Method /ATimepoint: N/A